Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations

30 August 2025 (17:30 - 17:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Alberto Cordero

Hospital San Juan de Alicante, Alicante (Spain)

5 More presentations in this session

Presentation thumbnail

How excess fat affects cardiac electrophysiology: preclinical obesity, clinical obesity with cardiac arrhythmias and ECG features

Doctor N. Zhang (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

Childhood adiposity affects cardiac structure, function and disease risk in later life: evidence of a causal association

Doctor D. Du (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Beyond BMI: the predictive value of body roundness index for premature all-cause and cardiovascular mortality: a national cohort study of US adults under 65

Doctor S. Abohashem (Boston, US)

Abstract Slides Video

Presentation thumbnail

Implications of obesity and metabolic health on coronary heart disease: an analysis of 157,159 participants in the UK Biobank

Doctor R. Ananda (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Adiposity-related anthropometrics, cardiovascular outcomes, and finerenone in heart failure and chronic kidney disease with type 2 diabetes: a FINE-HEART analysis

Doctor J. Ostrominski (Boston, US)

Abstract Slides Video

Access the full session

Session thumbnail

Challenges of managing obesity in cardiovascular disease

The Event

Event poster

ESC Congress 2025

30 August 2025 17:30 CET

You may be interested in

Congress Session

Late-Breaking Clinical Science: cardiometabolic medicine

Congress Session

Obesity and diabetes: risk assessment and prognosis

Congress Session

Risk stratification for midterm outcome after acute coronary syndromes

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources